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 on 9 August 2006  bjo.bmjjournals.com Downloaded from techniques are inevitable and should ensure that MRI
becomes an increasingly valuable tool which contributes
further to the understanding, and therefore management,
of ocular motor disturbances.
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Evaluation of corneal transplantation
Corneal transplantation is the most widely practised form
of clinical allografting.First successfully carried out almost
a century ago, its place in clinical practice was well estab-
lished before the vagaries of immunological privilege and
allograft rejection were appreciated.
Early on, the cornea and anterior segment of the eye
were established as ‘privileged sites’
1 which led to a widely
held view that corneal grafts were invariably successful.
This is far from the truth.
Paradoxically, corneal transplantation is both the most
successful and the least successful form of clinical
transplantation. Grafts done for dystrophic conditions,
particularly keratoconus, seldom reject, with a graft
survival rate of 50% after 5 years. However, grafts done for
acquired diseases fare badly.
23This is a great pity since
acquired corneal blindness is second to cataract as a cause
of visual loss on an international scale.
4
The mechanisms of these frequent failures are many.
Various factors account for the diVerences which are
reﬂected in the wide variations in outcome seen between
various centres. This variation is common in other
branches of transplantation, is referred to as the ‘centre
eVect’, and deﬁes speciﬁc elucidation.
5
Dissecting out the various factors contributing to graft
outcome demands extensive multicentric prospective
analyses. Vail and others report such a study in this issue of
the BJO (p 631). They conﬁrm some widely held clinical
beliefs, provide support for intuitions, and report some
new and perhaps unexpected ﬁndings.
In recent years, the importance of recipient factors has
been established and is further conﬁrmed by their study.
Corneal inﬂammation and vascularisation are known to be
associated with a high risk of rejection.
23 Inﬂammatory
disease erodes corneal privilege. Patients with acquired
diseases are much more likely to reject their corneal trans-
plants.
The importance of allograft rejection is further con-
ﬁrmed by the small but signiﬁcant beneﬁt bestowed by
class I HLA matching. That a degree of class II matching
was associated with less rejection than zero HLA-DR
matches
67 is interesting in view of an emerging under-
standing of the various mechanisms contributing to
corneal allograft rejection.It is generally believed that indi-
rect presentation of antigen is important in allograft
rejection
8 and particularly so in corneal rejection where the
graft carries fewer passenger cells.
The essential elements of this process involved the bone
marrow derived cells of the host, principally macrophages
and interstitial dendritic cells, presenting foreign histo-
compatibility antigens of the donor to the host
immunocytes.
8 This process is class II restricted. The con-
cept of indirect presentation of antigen is important in
understanding the biology of corneal allograft rejection
and in establishing the principles of management for
patients undergoing this procedure. Corneal allografts are
more likely to be rejected if placed in a recipient cornea
replete with high numbers of inﬂammatory cells.
9 Grafts
complicated, for one reason or another, by postoperative
inﬂammation are more likely to suVer allograft rejection.
10
Postoperative care is aimed at reducing the inﬂux of host
inﬂammatory cells into the graft. The use of non-reactive
monoﬁlament nylon sutures, the use of topical corticoster-
oids, the prompt and energetic treatment of inﬂammatory
events, such as infections or ulceration, are directed at
reducing the accumulation of host inﬂammatory cells in
the graft.
Of immediate relevance to the surgeon are the issues
where there is a choice in the management options of a
particular case.For example,all other things being equal,it
would seem better to avoid large grafts. This has been
observed in other studies.
3
The importance of clinicians making appropriate
decisions is emphasised by the better results achieved by
high volume surgeons. This diVerence is likely to be the
result of making better management decisions based on
greater experience than on better developed surgical skills.
Immediate post-surgical failure is uncommon.
It is important that the authors have taken the evaluation
of graft outcome beyond an assessment of endothelial fail-
ure. Not all grafts which are clear and functioning provide
good vision,
10 and not all grafts providing reasonable levels
of acuity contribute to the patient’s visual ability in the
general sense. Although the majority of grafts are done for
visual reasons the evaluation of their outcome is compli-
cated. Best corrected acuity is not always satisfactory for
patients. More relevant is the level of acuity with a form of
correction which is acceptable and usable by the patient.
Furthermore, binocular acuity is important. Visual ability
is related to vision in the better eye, rather than the worse
eye.
11 Unless patients achieve vision in the grafted eye bet-
ter than or comparable with the contralateral eye very little
is gained from the procedure.
The claim of Vail and his colleagues that, ‘Far more is
known concerning corneal transplantation in the UK than
was known at the outset of the Corneal Transplantation
Follow up Study’, is entirely justiﬁed. What is disappoint-
ing is that the authors have been forced to provide their
conclusions at such an early stage. As a 1 year study the
data will not supply anywhere near their full potential of
information. Transplantation is a long term intervention
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misleading. For example, the 1 year graft survival rate is
88% and, as the authors point out, is comparable with the
91% reported by the Australian Corneal Graft Registry at
1 year.
10 However, prolonged follow up of the Australian
patients demonstrates an alarming deterioration of grafts
with time. By 5 years the graft survival rate has fallen to
74% and by 10 years to 62%. Furthermore, any
assessment of acuity or visual function is not meaningful
within a year. Final acuity with a stable refraction is not
achievable within a year and often not within 3 years.
Studies like this should not be subject to the uncertain-
ties of grant funding with a ﬁnite time frame. They should
be mandatory. Evaluation along the lines described by Vail
and his colleagues is the only satisfactory way to evaluate
the process of transplantation and should be a part of the
operation of all eye banks.
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